SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Astrazeneca Pharma India informs about disclosure

03 Jul 2024 Evaluate
Astrazeneca Pharma India has informed that the current Site Lead India Operations - Mina Patel is completing her international assignment on July 31, 2024. She will be transitioning from the said role with effect from close of business hours July 31, 2024, as she takes up another responsibility within AstraZeneca group. Further informed that, based on the recommendation of the Nomination and Remuneration Committee, the Board of Directors of the Company have approved the appointment of Srikanth B.S. as Site Lead, India Operations with effect from August 1, 2024.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8519.80 11.00 (0.13%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×